UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 73

Sortiert nach

Benefits and Adverse Events in Younger Versus Older Patients Receiving Neoadjuvant Chemotherapy for Osteosarcoma: Findings From a Meta-Analysis

Journal of clinical oncology, 2013-06, Vol.31 (18), p.2303-2312

2013

Volltextzugriff (PDF)

Successful second bone marrow transplantation in a Wiskott-Aldrich syndrome patient with systemic vasculitis

Journal of allergy and clinical immunology, 2016-05, Vol.137 (5), p.1615-1616

2016

Volltextzugriff (PDF)

Liposarcoma: Molecular Genetics and Therapeutics

Sarcoma, 2011, Vol.2011, p.483154-13

2011

Volltextzugriff (PDF)

Exercise cardiovascular magnetic resonance reveals reduced cardiac reserve in pediatric cancer survivors with impaired cardiopulmonary fitness

Journal of cardiovascular magnetic resonance, 2020-09, Vol.22 (1), p.64-10, Article 64

2020

Volltextzugriff (PDF)

Minimising Adverse Drug Reactions and Verifying Economic Legitimacy-Pharmacogenomics Implementation in Children (MARVEL- PIC): protocol for a national randomised controlled trial of pharmacogenomics implementation

BMJ open, 2024-05, Vol.14 (5), p.e085115

2024

Volltextzugriff (PDF)

Prospective longitudinal evaluation of treatment-related toxicity and health-related quality of life during the first year of treatment for pediatric acute lymphoblastic leukemia

BMC cancer, 2022-09, Vol.22 (1), p.1-985, Article 985

2022

Volltextzugriff (PDF)

Pharmacogenomic studies of fertility outcomes in pediatric cancer survivors – A systematic review

Clinical and translational science, 2024-06, Vol.17 (6), p.e13827-n/a

2024

Volltextzugriff (PDF)

Promoting positive physical activity behaviors for children and adolescents undergoing acute cancer treatment: Development of the CanMOVE intervention using the Behavior Change Wheel

Frontiers in pediatrics, 2022-10, Vol.10, p.980890-980890

2022

Volltextzugriff (PDF)

A systematic review of knowledge, attitude and practice of pharmacogenomics in pediatric oncology patients

Pharmacology research & perspectives, 2023-12, Vol.11 (6), p.e01150-n/a

2023

Volltextzugriff (PDF)

A novel presentation of homozygous loss-of-function STAT-1 mutation in an infant with hyperinflammation—A case report and review of the literature

The journal of allergy and clinical immunology in practice (Cambridge, MA), 2016-07, Vol.4 (4), p.777-779

2016

Volltextzugriff (PDF)

Atypical Spitzoid neoplasms: a review of potential markers of biological behavior including sentinel node biopsy

Melanoma research, 2014-10, Vol.24 (5), p.437-447

2014

Volltextzugriff (PDF)

Physician-defined severe toxicities occurring during and after cancer treatment: Modified consensus definitions and clinical applicability in the evaluation of cancer treatment

Frontiers in pediatrics, 2023-04, Vol.11, p.1155449-1155449

2023

Volltextzugriff (PDF)

Lessons learnt in the first year of an Australian pediatric cardio oncology clinic

Cardio-oncology (London, England), 2023-12, Vol.9 (1), p.45-45, Article 45

2023

Volltextzugriff (PDF)

Evaluating anthracycline cardiotoxicity associated single nucleotide polymorphisms in a paediatric cohort with early onset cardiomyopathy

Cardio-oncology (London, England), 2020-05, Vol.6 (1), p.5-6, Article 5

2020

Volltextzugriff (PDF)

Pediatric Anthracycline‐Induced Cardiotoxicity: Mechanisms, Pharmacogenomics, and Pluripotent Stem‐Cell Modeling

Clinical pharmacology and therapeutics, 2019-03, Vol.105 (3), p.614-624

2019

Volltextzugriff (PDF)

Systematic review of pharmacogenomics and adverse drug reactions in paediatric oncology patients

Pediatric blood & cancer, 2018-04, Vol.65 (4), p.n/a

2018

Volltextzugriff (PDF)

Benchmarking pharmacogenomics genotyping tools: Performance analysis on short-read sequencing samples and depth-dependent evaluation

Clinical and translational science, 2024-08, Vol.17 (8), p.e13911

2024

Volltextzugriff (PDF)

Evaluating the measurement properties and feasibility of physical activity and physical function assessments for children undergoing acute cancer treatmentKey points

JSAMS plus, 2024-12, Vol.4, p.100065

2024

Volltextzugriff (PDF)

Evaluating the measurement properties and feasibility of physical activity and physical function assessments for children undergoing acute cancer treatment

JSAMS plus, 2024-12, Vol.4, p.100065, Article 100065

2024

Volltextzugriff (PDF)

Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome

Nature genetics, 2018-12, Vol.50 (12), p.1650

2018

Volltextzugriff (PDF)

Managing haematology and oncology patients during the COVID‐19 pandemic: interim consensus guidance

Medical journal of Australia, 2020-06, Vol.212 (10), p.481-489

2020

Volltextzugriff (PDF)

MARVEL-PIC: minimising adverse drug reactions and verifying economic legitimacy: pharmacogenomic implementation in children

Pathology, 2023-02, Vol.55, p.S17-S18

2023

Volltextzugriff (PDF)

MARVEL-PIC: minimising adverse drug reactions and verifying economic legitimacy: pharmacogenomic implementation in children

Pathology, 2023-02, Vol.55, p.S6-S6

2023

Volltextzugriff (PDF)

A systematic review investigating advances in gene therapy for Fanconi anemia over the last three decades

Frontiers in hematology, 2023-08, Vol.2

2023

Volltextzugriff (PDF)

Melatonin does not reduce delirium severity in hospitalized older adults: Results of a randomized placebo‐controlled trial

Journal of the American Geriatrics Society (JAGS), 2024-06, Vol.72 (6), p.1802-1809

2024

Volltextzugriff (PDF)

1 – 25 von 73

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(71)
Mit Volltextzugriff
(69)

Publikationsform

Artikel
(70)
Berichte
(2)
Reviews
(1)

Sprache

Englisch
(73)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Benefits and Adverse Events in Younger Versus Older Patients Receiving Neoadjuvant Chemotherapy for Osteosarcoma: Findings From a Meta-Analysis

Successful second bone marrow transplantation in a Wiskott-Aldrich syndrome patient with systemic vasculitis

Liposarcoma: Molecular Genetics and Therapeutics

Exercise cardiovascular magnetic resonance reveals reduced cardiac reserve in pediatric cancer survivors with impaired cardiopulmonary fitness

Minimising Adverse Drug Reactions and Verifying Economic Legitimacy-Pharmacogenomics Implementation in Children (MARVEL- PIC): protocol for a national randomised controlled trial of pharmacogenomics implementation

Prospective longitudinal evaluation of treatment-related toxicity and health-related quality of life during the first year of treatment for pediatric acute lymphoblastic leukemia

Pharmacogenomic studies of fertility outcomes in pediatric cancer survivors – A systematic review

Promoting positive physical activity behaviors for children and adolescents undergoing acute cancer treatment: Development of the CanMOVE intervention using the Behavior Change Wheel

A systematic review of knowledge, attitude and practice of pharmacogenomics in pediatric oncology patients

A novel presentation of homozygous loss-of-function STAT-1 mutation in an infant with hyperinflammation—A case report and review of the literature

Atypical Spitzoid neoplasms: a review of potential markers of biological behavior including sentinel node biopsy

Physician-defined severe toxicities occurring during and after cancer treatment: Modified consensus definitions and clinical applicability in the evaluation of cancer treatment

Lessons learnt in the first year of an Australian pediatric cardio oncology clinic

Evaluating anthracycline cardiotoxicity associated single nucleotide polymorphisms in a paediatric cohort with early onset cardiomyopathy

Pediatric Anthracycline‐Induced Cardiotoxicity: Mechanisms, Pharmacogenomics, and Pluripotent Stem‐Cell Modeling

Systematic review of pharmacogenomics and adverse drug reactions in paediatric oncology patients

Benchmarking pharmacogenomics genotyping tools: Performance analysis on short-read sequencing samples and depth-dependent evaluation

Evaluating the measurement properties and feasibility of physical activity and physical function assessments for children undergoing acute cancer treatmentKey points

Evaluating the measurement properties and feasibility of physical activity and physical function assessments for children undergoing acute cancer treatment

Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome

Managing haematology and oncology patients during the COVID‐19 pandemic: interim consensus guidance

MARVEL-PIC: minimising adverse drug reactions and verifying economic legitimacy: pharmacogenomic implementation in children

MARVEL-PIC: minimising adverse drug reactions and verifying economic legitimacy: pharmacogenomic implementation in children

A systematic review investigating advances in gene therapy for Fanconi anemia over the last three decades

Melatonin does not reduce delirium severity in hospitalized older adults: Results of a randomized placebo‐controlled trial

Suchergebnisse filtern